Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide

• Ing S. Tiong,
• William S. Stevenson,
• Meaghan Wall,
• Yan Zhuang Yap,
• John F. Seymour,
• Melita Kenealy,
• Piers Blombery,
• the Australasian Leukaemia & Lymphoma Group

Affiliations

Ing S. Tiong

Peter MacCallum Cancer Centre Melbourne Victoria Australia

William S. Stevenson

Royal North Shore Hospital St Leonards New South Wales Australia

Meaghan Wall

Monash University Melbourne Victoria Australia

Yan Zhuang Yap

Peter MacCallum Cancer Centre Melbourne Victoria Australia

John F. Seymour

Peter MacCallum Cancer Centre Melbourne Victoria Australia

Melita Kenealy

Monash University Melbourne Victoria Australia

Piers Blombery

Peter MacCallum Cancer Centre Melbourne Victoria Australia

the Australasian Leukaemia & Lymphoma Group

Peter MacCallum Cancer Centre Melbourne Victoria Australia